«Hashimoto Disease

Below is an extended Hashimoto Disease patents listing. Click here to return to the Hashimoto Disease main in depth entry.

Patents :
US Patent No.	Title
7074580	Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use
7189820	Antibodies against tumor necrosis factor delta (APRIL)
7189837	Cell surface molecule-induced macrophage activation
7192928	T cell antigen receptor peptides
7196181	Sequences encoding novel human thyroid peroxidase proteins and polypeptides
7196202	1-aryl-2-N-, S- or O-substituted benzimidazole derivatives, their use for the production of pharmaceutical agents as well as pharmaceutical preparations that contain these derivatives
7208527	Potassium channel modulators
7217797	Alteration of FcRn binding affinities or serum half-lives of antibodies by mutagenesis
7217798	Alteration of Fc-fusion protein serum half-lives by mutagenesis
7220840	Antibodies that immunospecifically bind to B lymphocyte stimulator protein
7235397	Methods and compositions for culturing spirochete and treating spirochetal diseases
7169603	.alpha.-MSH related compounds and methods of use
7163918	Iodothyronine compositions
7163802	Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use
7078027	Human endokine alpha
7091173	FAP48-interacting proteins and use thereof
7097829	Transgenic cells transfected with pituitary tumor transforming gene (PTTG)) expression vectors and uses therefor
7101869	2,4-diaminopyrimidine compounds useful as immunosuppressants
7105497	Methods of optimizing drug therapeutic efficacy for treatment of immune-mediated gastrointestinal disorders
7109319	FAIL molecules and uses thereof
7115259	Use of cytokines and mitogens to inhibit pathological immune responses
7135303	Regulators of type-1 tumor necrosis factor receptor and other cytokine receptor shedding
7138501	Antibodies that immunospecifically bind BLyS
7150885	Preventives/remedies for infection, anti-endtoxin agents, vaccine adjuvants and growth promoters
7244429	Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
7247630	Uses of tricyclic compounds
7348003	Methods of treating cancer using antibodies that immunospecifically bind to TRAIL receptors
7354584	Recombinant IL-9 antibodies
7361341	Methods of treating cancer using antibodies that immunospecifically bind to trail receptors
7361740	Alteration of FcRn binding affinities or serum half-lives of antibodies by mutagenesis
7365168	Alteration of FcRn binding affinities or serum half-lives of antibodies by mutagenesis
7368136	Preventives or remedies for infection, anti-endotoxin agents, vaccine adjuvants and growth promoters
7371383	Recombinant anti-interleukin-9 antibodies
7378444	Analogues of lipid mediators derived from omega-3 PUFAs and methods of use
7378492	CD40-related receptor that binds CD40L
7416745	Preventives or remedies for infection, anti-endotoxin agents, vaccine adjuvants and growth promoters
7347995	Compositions and methods for achieving immune suppression
7339065	Design and synthesis of optimized ligands for PPAR
7335743	Human anti-IFN-.gamma. neutralizing antibodies as selective IFN-.gamma. pathway inhibitors
7258853	Antagonists of interleukin-15
7271243	Full-length human cDNAs encoding potentially secreted proteins
7276606	Phenantridine analogues and uses thereof
7279160	Combinations of DR5 antibodies and other therapeutic agents
7279172	Treatment of autoimmune conditions with copolymer 1 and related copolymers
7285526	Interferon antagonists useful for the treatment of interferon related diseases
7317087	Members of the FC receptor homolog gene family (FCRH1-3, 6), related reagents, and uses thereof
7317089	Antagonistic anti-hTNFSF13b human antibodies
7323171	Methods of treating skin conditions using inhibitors of the CD2/LFA-3 interaction
7326694	Methods of optimizing drug therapeutic efficacy for treatment of immune-mediated gastrointestinal disorders
7417072	Blockade of Pin1 prevents cytokine production by activated immune cells

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.